menu
    • menu

    Company profile for Merus Pharmaceuticals

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Merus Pharmaceuticals is a leading Drug manufacturers & marketers situated in Excise free zone in Uttarakhand & recognized in the market, due to our ability to manufacture, export, supply a diverse and qualitative range of Non Beta Lactum Tablets, Bolus, Capsules, External Liquid Section, Dry Powder, Liquids, Veterinary Injectables, Large Volume Parental 500ml & Small Volume Injectables.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Merus Pharmaceuticalsindia-flag Flag
    Country
    Country
    India
    Address
    Address
    Plot No. 53-54, Bhura Rani Road Rudrapur, U.S. Nagar, Uttarakhand - 263153
    Telephone
    Telephone
    +91 9917090957
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.meruspharmaceuticals.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Merus cancer bispecific lives up to investors' expectations
    Merus cancer bispecific lives up to investors' expectations

    24 May 2024

    // James Waldron FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/asco-early-peak-merus-bispecific-cancer-data-lives-investors-expectations

    James Waldron FIERCE BIOTECH
    24 May 2024
    Share Share
    Merus Announces Poster Presentations for Zenocutuzumab and MCLA-129
    Merus Announces Poster Presentations for Zenocutuzumab and MCLA-129

    11 Mar 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/fr/news-release/2021/03/10/2190852/0/en/Merus-Announces-Poster-Presentations-for-Zenocutuzumab-and-MCLA-129-at-the-American-Association-for-Cancer-Research-2021-Annual-Meeting.html

    GLOBENEWSWIRE
    11 Mar 2021
    Share Share
    Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell
    Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell

    20 Jan 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/lilly-and-merus-nv-announce-collaboration-to-discover-novel-t-cell-re-directing-bispecific-antibodies-301210513.html

    PRNEWSWIRE
    20 Jan 2021
    Share Share
    Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell
    Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell

    18 Jan 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/lilly-and-merus-nv-announce-collaboration-to-discover-novel-t-cell-re-directing-bispecific-antibodies-301210513.html

    PRNEWSWIRE
    18 Jan 2021
    Share Share
    Merus Announces Collaborations with Nationwide Medical Organizations
    Merus Announces Collaborations with Nationwide Medical Organizations

    12 Jan 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/01/12/2157474/0/en/Merus-Announces-Collaborations-with-Nationwide-Medical-Organizations-in-the-Netherlands-and-Japan-to-Enhance-Screening-and-Identification-of-Cancer-Patients-with-NRG1-Fusion-Tumors.html

    GLOBENEWSWIRE
    12 Jan 2021
    Share Share
    Merus Announces Presentation of Phase 1 Clinical Data for MCLA-158
    Merus Announces Presentation of Phase 1 Clinical Data for MCLA-158

    11 Jan 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/fr/news-release/2021/01/11/2156649/0/en/Merus-Announces-Presentation-of-Phase-1-Clinical-Data-for-MCLA-158-at-the-American-Society-of-Clinical-Oncology-ASCO-2021-Gastrointestinal-Cancers-Symposium.html

    GLOBENEWSWIRE
    11 Jan 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search